Atlas Trials

Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy

Clinical trial NCT02375334 · TERMINATED

Trial details

NCT number
NCT02375334
Sponsor
Wake Forest University Health Sciences
Status
TERMINATED
Study type
OBSERVATIONAL
Malignant GliomaMyelosuppression
Start date
2015-02-01
Primary completion
2017-01-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.